Search

Measurements of pH drift were used to assess the ability of 38 red algal seaweeds to use bicarbonate and to deplete the dissolved inorganic carbon pool (DIC) from seawater medium. Subtidal algae were typically restricted to the use of DIC in the form of dissolved CO2, reducing the initial DIC by only 9%. Intertidal species used both dissolved CO2 and bicarbonate and reduced initial DIC by as much as 70%. DIC reductions and pH compensation points for the intertidal species tested were strongly correlated with their vertical zonation on the rocky shoreline (analysis of variance). DIC acquisition efficiency increased with tidal height, but species from the upper edge of the intertidal demonstrated a reversal of this trend. This general pattern associated with tidal height was observed not only among intertidal red algae in general, but also among four species of the genusPorphyra(P. tortaV. Krishnamurthy,P. papenfussiiKrishnamurthy,P. perforataJ. Agardh,P. fucicolaKrishnamurthy) and among four populations of the broadly distributed speciesMastocarpus papillatus(C. Agardh). TheMastocarpusobservations suggest either that individuals of this species may be able to express alternate strategies for carbon acquisition or that intertidal height may select for survivorship of genotypes with different carbon acquisition strategies. Taken together, these data suggest that the carbon acquisition strategy of intertidal red algae may be an important physiological set of adaptations that is under active evolutionary selection. These physiological differences were not related to phylogeny, tested as membership in red algal families and orders. [ABSTRACT FROM AUTHOR]

Chronic Lymphocytic Leukemia (CLL) patients with +12 have been reported to have specific clinical and biologic features. We performed an analysis of the association between demographic; clinical; laboratory; biologic features and outcome in CLL patients with +12 to identify parameters predictive of disease progression; time to treatment; and survival. The study included 487 treatment-naive CLL patients with +12 from 15 academic centers; diagnosed between January 2000 and July 2016; and 816 treatment-naïve patients with absence of Fluorescence In Situ Hybridization (FISH) abnormalities. A cohort of 250 patients with +12 CLL followed at a single US institution was used for external validation. In patients with +12; parameters associated with worse prognosis in the multivariate model were high Lactate DeHydrogenase (LDH) and β-2-microglobulin and unmutated immunoglobulin heavy-chain variable region gene (IGHV). CLL patients with +12 and high LDH levels showed a shorter Progression-Free-Survival (PFS) (30 months vs. 65 months; p < 0.001), Treatment-Free-Survival (TFS) (33 months vs. 69 months; p < 0.001), Overall Survival (OS) (131 months vs. 181 months; p < 0.001) and greater CLL-related mortality (29% vs. 11% at 10 years; p < 0.001) when compared with +12 CLL patients with normal LDH levels. The same differences were observed in the validation cohort. These data suggest that serum LDH levels can predict PFS; TFS; OS and CLL-specific survival in CLL patients with +12. [ABSTRACT FROM AUTHOR]